Bednarek Dariusz, Kondracki Marian, Friton Gabriele M, Trela Tomasz, Niemczuk Krzysztof
National Veterinary Research Institute, Pulawy, Poland.
Berl Munch Tierarztl Wochenschr. 2005 Jul-Aug;118(7-8):305-8.
The influence of treatment with steroidal (SAIDs) and non-steroidal (NSAIDs) anti-inflammatory drugs on inflammatory markers in thirty, 6-8 week old calves with induced bronchopneumonia was investigated. Animals received a single intravenous treatment with meloxicam (0.5 mg/kg body weight), flumethasone (0.05 mg/kg body weight) or sterile 0.9% NaCl (10 ml per animal). Body temperature, respiratory and heart rate, concentration of prostaglandins PGE2, PGF2alpha, thromboxane (TXB2), leukotriene (LTB4) and malonyldialdehyd (MDA) and proinflammatory cytokines i.e. tumor necrosis factor (TNFalpha) and interferon (INFalpha) were recorded in serum, bronchoalveolar lavage (BAL) and blood platelets (BP). A significant reduction of main inflammatory mediators PGE2, PGF2alpha,TXB2 and MDA after meloxicam treatment in calves with induced bronchopneumonia indicates a beneficial effect on the inflammatory processes. Contrary to effects observed by flumethasone, meloxicam induced an increase of LTB4 and INFalpha indicating that it is not immunosuppressive.
研究了甾体类抗炎药(SAIDs)和非甾体类抗炎药(NSAIDs)对30头6 - 8周龄诱发性支气管肺炎犊牛炎症标志物的影响。动物接受了美洛昔康(0.5 mg/kg体重)、氟米松(0.05 mg/kg体重)或无菌0.9%氯化钠(每头动物10 ml)的单次静脉治疗。记录了血清、支气管肺泡灌洗(BAL)和血小板(BP)中的体温、呼吸和心率、前列腺素PGE2、PGF2α、血栓素(TXB2)、白三烯(LTB4)和丙二醛(MDA)的浓度以及促炎细胞因子,即肿瘤坏死因子(TNFα)和干扰素(INFα)。美洛昔康治疗诱发性支气管肺炎犊牛后,主要炎症介质PGE2、PGF2α、TXB2和MDA显著降低,表明对炎症过程有有益作用。与氟米松观察到的效果相反,美洛昔康诱导LTB4和INFα增加,表明它没有免疫抑制作用。